CJC-1295 + Ipamorelin 10mg

CJC-1295 + Ipamorelin is a research combination studied for growth-hormone release and related signaling pathways. Researchers examine how the two compounds interact with different hormone-signaling mechanisms. Alpha Tides PNW supplies this blend strictly for laboratory research use.

Technical Research Details
CJC-1295 and Ipamorelin are research compounds studied in relation to growth hormone secretagogue and receptor signaling pathways. CJC-1295 is a modified GHRH analog studied for its interaction with GHRH receptor-mediated signaling, while Ipamorelin is studied for its interaction with ghrelin receptor pathways.
Together, these compounds may be examined in laboratory settings to compare complementary receptor mechanisms, signaling dynamics, and downstream biological pathways. The combination provides researchers with a multi-compound model for investigating receptor-mediated signaling in controlled experimental environments.

Research Applications

Receptor signaling research: Examining GHRH and ghrelin receptor-mediated signaling pathways in controlled research models
Comparative receptor studies: Evaluating differences in receptor interaction and signaling characteristics
Downstream signaling research: Investigating associated cellular signaling pathways and experimental response patterns
Receptor selectivity studies: Comparing receptor interaction profiles among related research compounds
Multi-compound research models: Examining how multiple research compounds may be studied within controlled experimental designs

Purity
99.75%
Where the Research Stands
Preclinical and laboratory research has examined the receptor pharmacology and signaling characteristics associated with CJC-1295 and Ipamorelin. Researchers have used these compounds as reference tools when studying GHRH-related and ghrelin receptor pathways, including differences in receptor selectivity and downstream signaling responses.
The available research literature provides a basis for further investigation of these pathways in controlled experimental settings.

Product Information

Form: Lyophilized powder blend
Contents: CJC-1295 5mg + Ipamorelin 5mg per vial
Total: 10mg per vial
Storage: −20°C lyophilized; 2–8°C after reconstitution
Reconstitution: Bacteriostatic water
Use: For laboratory and in vitro research use only

Frequently Asked Questions
Why are CJC-1295 and Ipamorelin studied together?
They act on two different receptors in the GH axis — CJC-1295 on the GHRH receptor and Ipamorelin on the ghrelin receptor. Studying them together lets researchers model complementary, dual-pathway stimulation that more closely resembles natural pulsatile GH release than either compound alone.
What is the difference between CJC-1295 and Ipamorelin?
CJC-1295 is a GHRH analog providing sustained receptor engagement; Ipamorelin is a selective ghrelin-receptor agonist producing faster, more immediate GH pulses with minimal cortisol or prolactin activity in preclinical models.
How is the blend reconstituted and stored?
Reconstitute with bacteriostatic water and store lyophilized vials at −20°C. After reconstitution, refrigerate at 2–8°C and avoid freeze-thaw cycles. See our full CJC-1295 + Ipamorelin research guide for detailed reconstitution and storage notes.
Is a Certificate of Analysis available for this product?
Yes. Supplier-provided laboratory documentation is available for this product, testing the wholesale lot prior to individual vial packaging. This report was not independently commissioned by Alpha Tides PNW — see our Certificates of Analysis page for the full document and source notes.
Research Use Only
This product is supplied exclusively for qualified laboratory research and analytical purposes. It is not intended for personal use, self-administration, human consumption, or animal use. The purchaser is responsible for ensuring that all research activities comply with applicable laws, regulations, and institutional requirements.